BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 22151997)

  • 1. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
    Chimge NO; Baniwal SK; Little GH; Chen YB; Kahn M; Tripathy D; Borok Z; Frenkel B
    Breast Cancer Res; 2011; 13(6):R127. PubMed ID: 22151997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis.
    Ding X; Park SI; McCauley LK; Wang CY
    J Biol Chem; 2013 Apr; 288(15):10241-53. PubMed ID: 23447531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
    Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
    Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor-α-miR-1271-SNAI2 feedback loop regulates transforming growth factor-β-induced breast cancer progression.
    Liu BW; Yu ZH; Chen AX; Chi JR; Ge J; Yu Y; Cao XC
    J Exp Clin Cancer Res; 2019 Mar; 38(1):109. PubMed ID: 30823890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis.
    Qureshi R; Picon-Ruiz M; Sho M; Van Booven D; Nunes de Paiva V; Diaz-Ruano AB; Ince TA; Slingerland J
    Cell Rep; 2022 Nov; 41(7):111672. PubMed ID: 36384125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effects of Runx2 and estradiol on breast cancer cell proliferation: in vitro identification of reciprocally regulated gene signature related to clinical letrozole responsiveness.
    Chimge NO; Baniwal SK; Luo J; Coetzee S; Khalid O; Berman BP; Tripathy D; Ellis MJ; Frenkel B
    Clin Cancer Res; 2012 Feb; 18(3):901-11. PubMed ID: 22147940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer.
    Li GY; Wang W; Sun JY; Xin B; Zhang X; Wang T; Zhang QF; Yao LB; Han H; Fan DM; Yang AG; Jia LT; Wang L
    Theranostics; 2018; 8(10):2846-2861. PubMed ID: 29774079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression.
    Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
    Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
    Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
    Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasiveness.
    Little GH; Baniwal SK; Adisetiyo H; Groshen S; Chimge NO; Kim SY; Khalid O; Hawes D; Jones JO; Pinski J; Schones DE; Frenkel B
    Cancer Res; 2014 May; 74(10):2857-68. PubMed ID: 24648349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine 1-phosphate signaling induces SNAI2 expression to promote cell invasion in breast cancer cells.
    Wang W; Hind T; Lam BWS; Herr DR
    FASEB J; 2019 Jun; 33(6):7180-7191. PubMed ID: 30844311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.
    Baniwal SK; Khalid O; Gabet Y; Shah RR; Purcell DJ; Mav D; Kohn-Gabet AE; Shi Y; Coetzee GA; Frenkel B
    Mol Cancer; 2010 Sep; 9():258. PubMed ID: 20863401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
    Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
    J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
    Mendoza-Villanueva D; Zeef L; Shore P
    Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIB1 cooperates with ERα to promote epithelial mesenchymal transition in breast cancer through SNAI1 activation.
    Wang M; Zhao F; Li S; Chang AK; Jia Z; Chen Y; Xu F; Pan H; Wu H
    PLoS One; 2013; 8(6):e65556. PubMed ID: 23762395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas.
    Niu DF; Kondo T; Nakazawa T; Oishi N; Kawasaki T; Mochizuki K; Yamane T; Katoh R
    Lab Invest; 2012 Aug; 92(8):1181-90. PubMed ID: 22641097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
    Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
    Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.